Has Peter Mangone, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,137,502 in general payments to Peter Mangone, MD across 816 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter Mangone, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter Mangone, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter Mangone, MD

Foot and Ankle Surgery · Pittsburgh, PANPI 1023065240

Payments from drug & device makers

$1,137,502in general payments, 2019–2025

Across 816 payments — averaging $1394.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$656K
Arthrex$264K
International Life Sciences$82K
Osteocentric Technologies, Inc.$49K
Restor3d, Inc.$49K
Kuros Biosciences USA, Inc$14K
plus $23K from 43 others

$4,245in research payments, 2019–2025

Across 32 payments — averaging $132.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$4K

What the payments were for

Royalty or licence$362,23832%
Consulting fees$612,07354%
Speaking & faculty fees$51,1035%
Travel & lodging$83,6577%
Food & beverage$21,3322%
Education$1,2000%
Gifts$1080%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker(2 entities)	545	$656,099
Arthrex	31	$263,778
International Life Sciences	13	$82,027
Osteocentric Technologies, Inc.	62	$49,371
Restor3d, Inc.	34	$48,822
Kuros Biosciences USA, Inc	14	$14,325
Vilex LLC	19	$8,480
Trice Medical, Inc.	5	$4,267
Velano Vascular, Inc.	1	$3,908
Peerless Surgical Inc.	5	$1,267
Treace Medical Concepts, Inc.	8	$1,015
Paragon 28, Inc.	6	$633
Zimmer Biomet	5	$501
Smith+Nephew	2	$279
Medshape, Inc.	3	$261
Mid-atlantic Surgical Systems, LLC	7	$250
Ossio Inc	3	$198
Exactech, Inc.	2	$191
Abbott	8	$183
Acumed LLC	1	$147
BREG, Inc	3	$141
Crossroads Extremity Systems, LLC	3	$139
Gramercy Extremity Orthopedics LLC	2	$126
Baxter Healthcare	1	$125
Kerecis Limited	2	$116
Sanara Medtech Inc.	1	$114
Heron Therapeutics, Inc.	4	$93
Vertex	3	$75
Voom Medical Devices, Inc.	1	$71
Anika Therapeutics, Inc.	1	$54
Axogen	1	$49
Medical Device Business Services, Inc.	2	$42
Medartis Inc.	1	$40
Nevro Corp.	2	$32
Theramicro, Inc.	1	$26
Carestream Health, Inc.	1	$26
Arthrosurface Incorporated	1	$25
Medtronic	1	$25
Radius Health, Inc.	1	$21
BD	1	$20
EBI, LLC	1	$20
ERMI LLC	1	$19
Amgen	1	$18
Trilliant Surgical LLC.	1	$15
Pacira Pharmaceuticals Incorporated	1	$15
Daiichi Sankyo Inc.	1	$14
Globus Medical	1	$13
Mallinckrodt Enterprises LLC	1	$12
Zyla Life Sciences, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$994,454
PROstep$291,284
INFINITY$89,041
DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ANCHORS$61,664
PROPHECY$52,660
INBONE$48,919
HOFFMANN$48,628
R&D Foot and Ankle$45,692
FLEXBAND$44,747
DISTAL EXTREMITIES IMPLANTS SOFT TISSUE IB LIGAMENT AUGMENTATION$33,700
ORTHOLOC 2 LAPIFUSE$30,713
OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST$22,490
Unifi Technology$20,688
GRAVITY$18,113
PROSTEP MICA$17,725
EASY CLIP$17,588
EASYFUSE$17,588
INVISION$16,215
VARIAX$14,372
MagnetOs$14,008

How this compares

$1,137,502 in reported general payments places this provider in the 95th percentile of 575 foot and ankle surgery providers in Pennsylvania.

See all foot and ankle surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$145,708

Medicare patients

289

Services billed

1,376

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	11	$135
Oxycodone Hcl	14	$39

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Pittsburgh

Lisa Grant-McdonaldPittsburgh$198K
Patrick BurnsPittsburgh$38K
Sham PersaudPittsburgh$17K
Michael SaviskyPittsburgh$16K
William DecarboBelle Vernon$3.5M
David PedowitzBryn Mawr$1.7M
Noman SiddiquiScranton$1.3M
Stephen BrigidoBethlehem$656K
Guido LaportaDunmore$625K
Jason MillerMalvern$551K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →